Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Insulin Resistance in Prostate Cancer Patients on ADT
NCT04995978Phase 2Withdrawn
- Sponsor
- Saint Louis University
- Start
- Dec 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in insulin resistance (IR), sponsored by Saint Louis University. Planned start Dec 2021; status: withdrawn.
02
Drugs
pioglitazone
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT04995978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04995978.